MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment
Recruiting now
Conditions studied: Gastric Cancer, Gastric Adenocarcinoma, Malnutrition, Cachexia
In brief
The aim of this single-arm prospective, multicenter, cross-sectional study is to evaluate the nutritional status and body composition on tumor regression grade with bioelectrical impedance analysis in gastric cancer patients undergoing multimodal treatment. Results of this study will reveal whether nutritional status and body composition assessment based on bioelectrical impedance analysis will become a validated and objective tool to support clinical decisions in gastric cancer patients undergoing multimodal treatment.
Key facts
- Study ID
- NCT05723718
- Run by
- Medical University of Lublin
- People needed
- 125
- Starts
- 2022-12-20
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2023-02-13
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years
- Histologically confirmed gastric adenocarcinoma (or undifferentiated carcinoma)
- Stage II - III disease (cT2 cN+ and cT3-T4 cN+/-) based on the 8th edition of TNM classification
- Qualification for multimodal treatment by the decision of the multidisciplinary tumor board
You may not qualify if…
- Early gastric cancer (cT1N0-3M0) scheduled for endoscopic treatment by multidisciplinary team
- Gastric stump carcinoma
- Distant metastasis
- Upfront surgery
- Other malignancies
- Contraindications to bioelectrical impedance analysis (e.g., implanted cardiac devices, metal implants or pregnancy)
Where it is running
- Medical University of Lublin — Lublin, Poland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.